The Teleflex Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift® System, a minimally invasive permanent implant system that treats symptoms while preserving sexual function.*1
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit www.Teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®, Rusch®, UroLift® System and Weck® – trusted brands united by a common sense of purpose.
Source Information
*No instances of new, sustained erectile or ejaculatory dysfunction in the LIFT pivotal study
1. Roehrborn, J Urology 2017 LIFT Study
2. Roehrborn, J Urol 2013
3. AUA Guidelines 2003, 2020
4. Mirakhur, Can Assoc Rad J 2017
5. McVary, J Urol 2016
6.Gilling, Can J Urol 2020
7. Kadner, World J Urol 2021
Teleflex Medical Brasil Ltda
Rua Alexandre Dumas, 2100/132 - Chacara Santo Antonio
São Paulo/SP - CEP 04717-913
